Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa.
Factor IXChapel Hill (Factor IXCH), an abnormal Factor IX molecule isolated from the plasma of a patient with mild hemophilia B, has previously been shown to exhibit delayed activation by Factor XIa and calcium. In this study, we have found that Factor IXCH is cleaved upon incubation with human Fact...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1981
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC370943/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6976355/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110393 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
